Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients

[1] Parfrey PS(1999)The clinical epidemiology of cardiac disease in chronic renal failure J Am Soc Nephrol 10 1606-1615

[2] Foley RN(1992)Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients Am J Kidney Dis 20 32-38

[3] Harnett JD(1995)Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors Kidney Int 47 884-890

[4] Foley RN(2009)Predicting progression in nondiabetic kidney disease: the importance of cardiorenal interactions Kidney Int 75 253-255

[5] Kent GM(2008)Cardiorenal syndrome J Am Coll Cardiol 52 1527-1539

[6] Barre PE(2003)Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) Circulation 107 1278-1283

[7] Murray D(2002)Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure New Engl J Med 347 161-167

[8] Parfrey PS(2004)Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea New Engl J Med 350 647-654

[9] Breidthardt T(2002)A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation Am Heart J 144 834-839

[10] Mebazaa A(2001)Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling Mayo Clin Proc 76 1111-1119

[1] Parfrey PS(1999)The clinical epidemiology of cardiac disease in chronic renal failure J Am Soc Nephrol 10 1606-1615

[2] Foley RN(1992)Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients Am J Kidney Dis 20 32-38

[3] Harnett JD(1995)Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors Kidney Int 47 884-890

[4] Foley RN(2009)Predicting progression in nondiabetic kidney disease: the importance of cardiorenal interactions Kidney Int 75 253-255

[5] Kent GM(2008)Cardiorenal syndrome J Am Coll Cardiol 52 1527-1539

[6] Barre PE(2003)Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) Circulation 107 1278-1283

[7] Murray D(2002)Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure New Engl J Med 347 161-167

[8] Parfrey PS(2004)Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea New Engl J Med 350 647-654

[9] Breidthardt T(2002)A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation Am Heart J 144 834-839

[10] Mebazaa A(2001)Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling Mayo Clin Proc 76 1111-1119